H26.30 Drug-induced cataract, unspecified eye

Name of the Condition

• Drug-Induced Cataract, Unspecified Eye (ICD-10 Code: H26.30)

Summary

Drug-induced cataract, unspecified eye, refers to clouding of the lens in one or both eyes caused by medication use. This condition impairs vision by scattering or blocking light, potentially leading to reduced visual acuity or other visual disturbances. The term "unspecified eye" indicates the condition is not localized to a particular eye.

Causes

Drug-induced cataracts result from prolonged or high-dose use of medications that affect lens metabolism or structure. Common culprits include corticosteroids, certain antipsychotics, and chemotherapy agents. The exact mechanism varies by drug but often involves oxidative stress or disruption of lens protein synthesis.

Risk Factors

• Prolonged use of systemic or topical corticosteroids.
• Use of phenothiazine antipsychotics (e.g., chlorpromazine).
• Exposure to certain chemotherapy agents (e.g., busulfan).
• High cumulative doses of implicated medications.
• Pre-existing lens vulnerability (e.g., age-related changes).

Symptoms

• Blurred or hazy vision.
• Difficulty with night vision or glare sensitivity.
• Fading or yellowing of colors.
• Double vision in one eye.
• Frequent changes in eyeglass prescription.

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing, slit-lamp evaluation, and retinal assessment. Additional tests, such as lens photography or optical coherence tomography, may be used to characterize the cataract. A detailed medication history is critical to identify potential drug-related causes.

Treatment Options

• Surgical removal of the cloudy lens, typically replaced with an intraocular lens implant.
• Monitoring and management of underlying medication use, if possible.
• Vision correction with glasses or contact lenses if surgery is not immediately indicated.

Prognosis and Follow-Up

Prognosis depends on the severity of the cataract and response to treatment. Early intervention often improves outcomes. Regular follow-up with an ophthalmologist is recommended to monitor vision changes and adjust treatment as needed. Discontinuation of the causative drug, if feasible, may slow progression.

Complications

• Permanent vision loss if left untreated.
• Increased risk of falls or accidents due to impaired vision.
• Potential for secondary eye conditions, such as glaucoma or retinal detachment, in advanced cases.

Lifestyle & Prevention

• Avoid prolonged use of high-risk medications when alternatives exist.
• Use protective eyewear to reduce additional lens stress.
• Maintain regular eye exams, especially if on long-term medication regimens.
• Follow healthcare provider guidance on medication dosing and duration.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, increased glare sensitivity, or difficulty performing daily tasks. Prompt evaluation is essential to prevent permanent vision impairment.

Tips for Medical Coders

Document the specific eye affected (unspecified in this code) and any associated medication history. Ensure the code H26.30 is used when the cataract is drug-induced and not localized to a specific eye. Include details about the causative drug and duration of use in clinical notes for accurate coding and billing.